Cours Integrated BioPharma, Inc. Other OTC
Actions
INBP
US45811V1052
Produits pharmaceutiques
CA 2022 | 56,25 M 50,88 M | CA 2023 | 50,67 M 45,84 M | Capitalisation | 9,92 M 8,97 M |
---|---|---|---|---|---|
Résultat net 2022 | 3 M 2,71 M | Résultat net 2023 | - 0 | VE / CA 2022 | 0,3 x |
Dette nette 2022 | 1,71 M 1,55 M | Dette nette 2023 | 1,36 M 1,23 M | VE / CA 2023 | 0,22 x |
PER 2022 |
4,17
x | PER 2023 |
-292
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 20,22% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Riva Sheppard
CEO | Chief Executive Officer | 57 | 01/05/91 |
Christina Kay
CEO | Chief Executive Officer | 54 | 01/12/94 |
Dina Masi
DFI | Director of Finance/CFO | 63 | 17/11/05 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Christina Kay
CEO | Chief Executive Officer | 54 | 01/12/94 |
Damon Desantis
BRD | Director/Board Member | 56 | 20/06/22 |
Eric Friedman
BRD | Director/Board Member | 76 | 04/11/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
+21,85% | 546 Md | |
-4,77% | 359 Md | |
+16,97% | 323 Md | |
+5,69% | 290 Md | |
+13,68% | 234 Md | |
+3,65% | 198 Md | |
-11,12% | 194 Md | |
+8,08% | 167 Md | |
-3,40% | 157 Md |